CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
64 hedge funds and large institutions have $244M invested in Cymabay Therapeutics in 2017 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 22 increasing their positions, 6 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
64% more funds holding
Funds holding: 39 → 64 (+25)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
64
Holding in Top 10
3
Calls
$402K
Puts
$126K
Top Buyers
| 1 | +$18.9M | |
| 2 | +$18.8M | |
| 3 | +$13.7M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$13.3M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$12.1M |
Top Sellers
| 1 | -$3.74M | |
| 2 | -$2.06M | |
| 3 | -$461K | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$242K |
| 5 |
ACI
Alpha Cubed Investments
Irvine,
California
|
-$115K |